Cargando…
Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth
Neuroblastoma is frequently diagnosed at advanced stage disease and treatment includes high dose chemotherapy and surgery. Despite the use of aggressive therapy survival rates are poor and children that survive their disease experience long term side effects from their treatment, highlighting the ne...
Autores principales: | Vittorio, Orazio, Brandl, Miriam, Cirillo, Giuseppe, Kimpton, Kathleen, Hinde, Elizabeth, Gaus, Katharina, Yee, Eugene, Kumar, Naresh, Duong, Hien, Fleming, Claudia, Haber, Michelle, Norris, Murray, Boyer, Cyrille, Kavallaris, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216955/ https://www.ncbi.nlm.nih.gov/pubmed/27374085 http://dx.doi.org/10.18632/oncotarget.10201 |
Ejemplares similares
-
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
por: Yee, Eugene M. H., et al.
Publicado: (2017) -
In vivo [(64)Cu]CuCl(2) PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis
por: Parmar, Arvind, et al.
Publicado: (2018) -
Synthesis of Dextran–Phenoxodiol and Evaluation of Its Physical Stability and Biological Activity
por: Yee, Eugene M. H., et al.
Publicado: (2019) -
Dextran-Curcumin Nanosystems Inhibit Cell Growth and Migration Regulating the Epithelial to Mesenchymal Transition in Prostate Cancer Cells
por: Bevacqua, Emilia, et al.
Publicado: (2021) -
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation
por: Le Grand, Marion, et al.
Publicado: (2020)